Famoxadone belongs to FRAC Group 11 and disrupts energy metabolism in susceptible pathogens by inhibiting the Qo site of the mitochondrial cytochrome bc1 complex.
Cyazofamid belongs to FRAC Group 21 and affects normal respiratory activity in oomycetes by inhibiting the Qi site of the same respiratory complex.
Although both active ingredients act on the mitochondrial respiratory process, their specific binding sites differ, and they therefore belong to two distinct FRAC Groups.
This combination is primarily intended for certain Phytophthora and downy mildew-related oomycetal diseases and can serve as a candidate solution for disease control products on specific crops.
It should be noted that different target sites do not mean the product can ignore the risk of resistance. Both famoxadone and cyazofamid should be used in accordance with the relevant resistance management recommendations.
Importers should focus on target diseases, application timing, formulation stability, and registration requirements in target markets.
Supply Information
MaFa Agro provides supply consultations for Famoxadone 26% + Cyazofamid 14% SC and assists importers in coordinating packaging specifications, brand labeling, and technical documentation based on their procurement needs.
We can assist clients in confirming product quality requirements, formulation specifications, and conditions for bulk exports.